Managed by Pharvision Advisers, Llc • Latest filing Q1 2026
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
| 5 | W W — | $878K | 9.8K | 0.00% | — |
| 6 | N NFLX — | $873K | 979 | 0.00% | — |
| 7 | I IRDM — | $873K | 30.1K | 0.00% | — |
| 8 | M META — | $872K | 1.5K | 0.00% | — |
| 9 | T TSLA — | $852K | 2.1K | 0.00% | — |
| 10 | E EXLS — | $837K | 17.7K | 0.00% | — |
| 11 | B BAH — | $832K | 6.5K | 0.00% | — |
| 12 | E EXLS — | $830K | 19.5K | 0.00% | — |
| 13 | A AWK — | $821K | 6.6K | 0.00% | — |
| 14 | E EXLS — | $780K | 17.7K | 0.00% | — |
| 15 | E EXLS — | $776K | 17.7K | 0.00% | — |
| 16 | D DIS — | $751K | 6.7K | 0.00% | — |
| 17 | G GSCE — | $746K | 92.2K | 0.00% | — |
| 18 | T TIGR — | $734K | 68.8K | 0.00% | — |
| 19 | Q QCRH — | $732K | 105.0K | 0.00% | — |
| 20 | A ARRY — | $730K | 89.6K | 0.00% | — |